Selective cyclo-oxygenase-2 inhibition induces regression of autologous endometrial grafts by down-regulation of vascular endothelial growth factor-mediated angiogenesis and stimulation of caspase-3-dependent apoptosis
article
OA: closed
CC0
⤵ 72 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
Selective cyclo-oxygenase-2 inhibition causes autologous endometrial grafts to regress by reducing vascular endothelial growth factor-mediated angiogenesis and increasing caspase-3-dependent apoptosis.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (44)
- Angiogenese und Endometriose via openalex
- Angiogenic Factors in Endometriosis via openalex
- Angiongenesis: a new theory for endometriosis via openalex
- Combined inhibition of vascular endothelial growth factor (VEGF), fibroblast growth factor and platelet-derived growth factor, but not inhibition of VEGF alone, effectively suppresses angiogenesis and vessel maturation in endometriotic lesions via openalex
- Distribution of cyclooxygenase-2 in eutopic and ectopic endometrium in endometriosis and adenomyosis via openalex
- Expression of angiogenic factors in extrapelvic endometriosis via openalex
- Gonadotrophin-releasing hormone analogues for endometriosis: bone mineral density via openalex
- Immunohistochemical analysis of vascular endothelial growth factor cellular expression in ovarian endometriomata via openalex
- In vivo analysis of angiogenesis in endometriosis-like lesions by intravital fluorescence microscopy via openalex
- Medical Management of Endometriosis: Novel Targets and Approaches towards the Development of Future Treatment Regimes via openalex
- Medical Treatment of Endometriosis via openalex
- Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis. via openalex
- Regression of endometrial explants in rats treated with the cyclooxygenase-2 inhibitor rofecoxib via openalex
- Survivin Gene Expression in Endometriosis via openalex
- Vascular development in endometriosis via openalex
- W2141215190 via openalex
- W2146060718 via openalex
- W2148122132 via openalex
- W2158686638 via openalex
- W2159973565 via openalex
- W2165663767 via openalex
- W2346020725 via openalex
- W6606350513 via openalex
- W6629591972 via openalex
- W6655318352 via openalex
- W6659841928 via openalex
- W6674553020 via openalex
- W6681627999 via openalex
- W155792476 via openalex
- W6681761019 via openalex
- W1496912415 via openalex
- W1968316164 via openalex
- W1969169755 via openalex
- W1974922031 via openalex
- W1985959551 via openalex
- W2039274017 via openalex
- W2040095832 via openalex
- W2043707891 via openalex
- W2052582923 via openalex
- W2068885726 via openalex
- W2097620342 via openalex
- W2097716284 via openalex
- W2105803518 via openalex
- W2115475125 via openalex
Cited by (50)
- Endometriosis and ovulatory menstruation: beyond the Sampson principle 2025
- Research Progress of Caspase in Endometriosis 2024
- Effects of selective inhibition of prostaglandin E2 receptors EP2 and EP4 on the miRNA profile in endometriosis 2022
- Endometriosis, infertility and MicroRNA's: A review 2021
- PPARγ Agonists: Emergent Therapy in Endometriosis 2021
- Use of selective PGE2 receptor antagonists on human endometriotic stromal cells and peritoneal macrophages 2020
- Dose-Dependent Decreased Fertility in Response to the Burden of Endometriosis in a Murine Model 2019
- Suppressive Effects of Ursolic Acid on Human Endometriotic Stromal Cells Survival 2019
- Comparing The Effects of Glycyrrhiza glabra Root Extract, A Cyclooxygenase-2 Inhibitor (Celecoxib) and A Gonadotropin-Releasing Hormone Analog (Diphereline) in A Rat Model of Endometriosis. 2019
- Cyclooxygenase-2 in Endometriosis 2019
- Eutopic stromal cells of endometriosis promote neuroangiogenesis via exosome pathway† 2018
- 6-Shogaol reduces progression of experimental endometriosis<i>in vivo</i>and<i>in vitro via</i>regulation of VGEF and inhibition of COX-2 and PGE2-mediated inflammatory responses 2018
- Basic mechanisms of vascularization in endometriosis and their clinical implications 2018
- Concentration effect of prostaglandin E<sub>2</sub> on the growth factor expression and cell proliferation in bovine endometrial explants and their kinetic characteristics 2017
- Combination therapy with telmisartan and parecoxib induces regression of endometriotic lesions 2017
- Summary of Future Developments 2017
- Targeting hypoxia‐mediated YAP1 nuclear translocation ameliorates pathogenesis of endometriosis without compromising maternal fertility 2017
- Recent advances in the understanding of endometriosis: the role of inflammatory mediators in disease pathogenesis and treatment 2016
- Inhibition of Hyaluronic Acid Synthesis Suppresses Angiogenesis in Developing Endometriotic Lesions 2016
- Hypoxia-inducible factor-1alpha: A promising therapeutic target in endometriosis 2016
- -1195 A/G promoter variants of the cyclooxygenase-2 gene increases the risk of pain occurrence in endometriotic women 2016
- COX-2 gene promoter DNA methylation status in eutopic and ectopic endometrium of Egyptian women with endometriosis 2015
- A rare case of endometrioma in a bitch 2015
- Molecular and preclinical basis to inhibit PGE <sub>2</sub> receptors EP2 and EP4 as a novel nonsteroidal therapy for endometriosis 2015
- MAP kinases and the inflammatory signaling cascade as targets for the treatment of endometriosis? 2015
- Selective inhibition of prostaglandin E2 receptors EP2 and EP4 modulates DNA methylation and histone modification machinery proteins in human endometriotic cells 2015
- Roles of Prostaglandin E2 in Endometriosis 2014
- CD26/DPPIV down-regulation in endometrial stromal cell migration in endometriosis 2014
- Combined blockade of angiotensin II type 1 receptor and activation of peroxisome proliferator-activated receptor- by telmisartan effectively inhibits vascularization and growth of murine endometriosis-like lesions 2014
- A Critical Review of Endometriosis Pathology 2013
- Pathogenesis of endometriosis: The role of initial infection and subsequent sterile inflammation (Review) 2013
- Suppression of annexin A2 by prostaglandin E2 impairs phagocytic ability of peritoneal macrophages in women with endometriosis 2013
- Identification of multiple and distinct defects in prostaglandin biosynthetic pathways in eutopic and ectopic endometrium of women with endometriosis 2013
- Regression of Experimentally Induced Endometriosis with a New Selective Cyclooxygenase-2 Enzyme Inhibitor 2013
- Selective Inhibition of Prostaglandin E2 Receptors EP2 and EP4 Inhibits Adhesion of Human Endometriotic Epithelial and Stromal Cells Through Suppression of Integrin-Mediated Mechanisms1 2012
- Non-hormonal targets for the medical treatment of endometriosis 2012
- Peritoneal endometriosis is an inflammatory disease 2012
- New perspectives for the treatment of endometriosis 2012
- Anastrozole and celecoxib for endometriosis treatment, good to keep them apart? 2012
- Regulación del crecimiento del tejido endometrial en respuesta a nuevas alternativas terapéuticas propuestas para tratar la endometriosis 2012
- Anti-angiogenic treatment strategies for the therapy of endometriosis 2012
- The translational challenge in the development of new and effective therapies for endometriosis: a review of confidence from published preclinical efficacy studies 2011
- <i>In vitro</i> and <i>in vivo</i> evaluation of the anti‐angiogenic actions of 4‐hydroxybenzyl alcohol 2011
- Hypoxia induces expression of COX-2 through the homeodomain transcription factor CDX1 and orphan nuclear receptor SHP in human endometrial cells 2011
- Hypoxia‐inhibited dual‐specificity phosphatase‐2 expression in endometriotic cells regulates cyclooxygenase‐2 expression 2011
- The inducible prostaglandin E synthase mPGES-1 regulates growth of endometrial tissues and angiogenesis in a mouse implantation model 2010
- Expression of COX-2 in Intestinal Endometriosis to: Tokyol C, et al. Int J Gynecol Pathol 2009;28:148–56 2010
- Prostaglandin E <sub>2</sub> : the master of endometriosis? 2010
- Suppression of migratory/invasive ability and induction of apoptosis in adenomyosis-derived mesenchymal stem cells by cyclooxygenase-2 inhibitors 2010
- Genistein Does Not Affect Vascularization and Blood Perfusion of Endometriotic Lesions and Ovarian Follicles in Dorsal Skinfold Chambers of Syrian Golden Hamsters 2010
Source provenance
- europepmc
- last seen: 2026-06-11T06:19:48.454388+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:15:12.369988+00:00
- unpaywall
- last seen: 2026-06-02T02:00:03.124865+00:00
License: CC0
· commercial use OK